CAMUCRI: Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island

Sponsor

Centre Hospitalier Universitaire de la Réunion (Other)

Overall Status

Recruiting

CT.gov ID

NCT04932681

Collaborator

APLAMEDOM (Other)

520

Enrollment

Locations

Anticipated Duration (Months)

260

Patients Per Site

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Exploratory, observational and cross-sectional study with the aim of describing the use of plants for medicinal purposes (and other Complementary and Alternative Medicine) and identifying the determinants of this use. The methodology envisaged is mixed with an exploratory design combining qualitative (interviews) and quantitative techniques (questionnaires).

To knowledge of investigators, no study has been carried out in Reunion Island on the use of plants and other alternative and complementary medicines among cancer patients.

Condition or Disease	Intervention/Treatment	Phase
Cancer

Study Design

Study Type:

Observational

Anticipated Enrollment :

520 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Evaluation of the Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island

Anticipated Study Start Date :

Apr 1, 2022

Anticipated Primary Completion Date :

Apr 1, 2023

Anticipated Study Completion Date :

Dec 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
Qualitative group Interview about the use of Complementary and Alternative Medecine
Quantitative group Questionnaire about the use of Complementary and Alternative Medecine

Outcome Measures

Primary Outcome Measures

Use of herbal medicine [Day 1]
Proportion of patients using herbal medicine (from the patient's perspective) among cancer patients.

Secondary Outcome Measures

Barriers of dialogue between patient and practionner [Day 1]
Interviews between patient and interviewer will help to extract the barriers limiting patient/practitioner dialogue on Complementary and Alternative Medicine use from patient and practitioner perspectives
Need for Information on Complementary and Alternative Medicine [Day 1]
Interviews between patient and interviewer will help to find out expectations about the need for information on Complementary and Alternative Medicine use from the patient's perspective and from the practitioner's perspective
Improving questionnaire after the practionners' focus group [Day 1]
A practionners' focus group will be organised after the interviews to review the feedbacks and opinions on the questionnaire to improve the questionnaire for the quantitative part of the study

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Living in Reunion Island
Suffering from cancer (solid tumors, hematological malignancies)
Able to answer a questionnaire
Patient who does not oppose to the research

Exclusion Criteria:

Person of legal age under guardianship or under legal protection
Persons who do not understand French or Reunionese Creole

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU La Réunion	Saint-Denis		Réunion	97400
2	Clinique Saint Clotilde	Sainte-Clotilde		Réunion	97490

Sponsors and Collaborators

Centre Hospitalier Universitaire de la Réunion
APLAMEDOM

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Centre Hospitalier Universitaire de la Réunion

ClinicalTrials.gov Identifier:

NCT04932681

Other Study ID Numbers:

2021/CHU/05

First Posted:

Jun 21, 2021

Last Update Posted:

Apr 8, 2022

Last Verified:

Mar 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Apr 8, 2022